Loperamide Hydrochloride capsules, USP, 2 mg, 100-count bottle, Rx only, MFG: Mylan Pharma, NDC 0378-2100-01
Check against the official notice below — it lists the full affected range.
McKesson Medical-Surgical Inc. is recalling Loperamide Hydrochloride capsules, USP, 2 mg in 100-count bottles manufactured by Mylan Pharma due to temperature abuse during storage or handling that violated good manufacturing practice standards. The recall affects one bottle distributed nationwide across the United States.
McKesson was unable to identify which specific lot numbers were received by individual customers, but provided distribution dates to affected customers indicating when the impacted product may have been shipped to them. The source document does not specify a remedy or corrective action for affected consumers.
Written by software from the official notice below. Not reviewed by a lawyer.
cGMP deviations: Temperature abuse
Reason for recall: cGMP deviations: Temperature abuse Distribution: USA nationwide. Quantity: 1 bottle/100 capsules Lot/code info: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.
Official record: FDA (Drug enforcement) ↗
Republished from the official source above; details can change — the source record controls.